Abstract
Background: iPREDICT aimed to predict asthma control changes using digital sensor technology (Hagger L et al., AJRCCM 2019). Objectives: With data on common, noninvasive biomarkers, we evaluated algorithms to identify patient-specific triggers and predict changes in asthma control. Methods: In a 24-wk pilot study, 108 US pts with severe asthma interacted with 3 sensors, 1–2 connected devices, and 2 mobile applications. An asthma event (endpoint) was defined as asthma symptom worsening (either logged by pts, PEF 8 SABA puffs in 24h, or >4 puffs/day over 48h). For each endpoint, predictive models were built at population, subgroup, and individual levels (fig). Results: Predictive accuracy depended on endpoint selection. Because of disease heterogeneity, population-level models inaccurately predicted asthma endpoints. Subgroup models (most accurate predictive endpoint: >4 puffs/day over 48h) had relatively high accuracy for certain groups (fig). Individual models were reasonably accurate, with sufficient, good-quality data. Analysis of high-accuracy individual models indicated important predictive biomarkers for each endpoint, which differed greatly between pts. Conclusion: We demonstrated the feasibility of developing subgroup and individual predictive models in asthma. These models, continuously trained on pts’ own data, could potentially predict asthma events with relative accuracy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.